BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 28663004)

  • 1. Omission of Radiotherapy for Women With Low-Risk Invasive Cancers That Have a Ductal Carcinoma In Situ Component.
    Sorscher S
    J Clin Oncol; 2024 Jun; 42(16):1998. PubMed ID: 38489565
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of endocrine treatment on the risk of developing an ipsilateral invasive breast cancer in hormone receptor positive patients with ductal carcinoma in situ.
    Altundag K
    Breast Cancer Res Treat; 2024 Feb; 204(1):189-190. PubMed ID: 38051408
    [No Abstract]   [Full Text] [Related]  

  • 3. Ductal carcinoma in situ with and without microinvasion: is there a clinically meaningful difference in outcome?
    Canas-Marques R; Schnitt SJ
    Br J Cancer; 2023 Mar; 128(5):713-714. PubMed ID: 36707635
    [No Abstract]   [Full Text] [Related]  

  • 4. Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ.
    Schmidt MK; Lips EH; Schmitz RS; Verschuur E; Wesseling J
    BMJ; 2024 Jan; 384():q22. PubMed ID: 38267067
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Comment: Management of Low-Risk Ductal Carcinoma In Situ-What We Need to Know at a Time of Shifting Perceptions.
    Igarashi T
    AJR Am J Roentgenol; 2024 Mar; 222(3):e2330739. PubMed ID: 38170834
    [No Abstract]   [Full Text] [Related]  

  • 6. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
    Wiechmann L; Kuerer HM
    Cancer; 2008 May; 112(10):2130-42. PubMed ID: 18383519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland.
    Tang SS; Kaptanis S; Haddow JB; Mondani G; Elsberger B; Tasoulis MK; Obondo C; Johns N; Ismail W; Syed A; Kissias P; Venn M; Sundaramoorthy S; Irwin G; Sami AS; Elfadl D; Baggaley A; Remoundos DD; Langlands F; Charalampoudis P; Barber Z; Hamilton-Burke WLS; Khan A; Sirianni C; Merker LAG; Saha S; Lane RA; Chopra S; Dupré S; Manning AT; St John ER; Musbahi A; Dlamini N; McArdle CL; Wright C; Murphy JO; Aggarwal R; Dordea M; Bosch K; Egbeare D; Osman H; Tayeh S; Razi F; Iqbal J; Ledwidge SFC; Albert V; Masannat Y
    Eur J Cancer; 2017 Oct; 84():315-324. PubMed ID: 28865259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
    Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
    Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study.
    van Deurzen CH
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):627-633. PubMed ID: 27590331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive Nipple Margins in Nipple-Sparing Mastectomies: Rates, Management, and Oncologic Safety.
    Tang R; Coopey SB; Merrill AL; Rai U; Specht MC; Gadd MA; Colwell AS; Austen WG; Brachtel EF; Smith BL
    J Am Coll Surg; 2016 Jun; 222(6):1149-55. PubMed ID: 27118712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of margins in invasive carcinoma and ductal carcinoma in situ: The pathologist's perspective.
    Schnitt SJ
    Breast; 2017 Aug; 34 Suppl 1():S58-S60. PubMed ID: 28663004
    [No Abstract]   [Full Text] [Related]  

  • 13. [Breast cancer from the viewpoint of the pathologist].
    Reiner A
    Wien Med Wochenschr; 2000; 150(4):58-62. PubMed ID: 10829305
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.